Credit Suisse’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $263K | Buy |
|
|||||
|
2023
Q1 | $368K | Buy |
|
|||||
|
2022
Q4 | $347K | Buy |
|
|||||
|
2022
Q3 | $229K | Buy |
|
|||||
|
2022
Q2 | $378K | Sell |
|
|||||
|
2022
Q1 | $439K | Buy |
|
|||||
|
2021
Q4 | $443K | Buy |
|
|||||
|
2021
Q3 | $480K | Sell |
|
|||||
|
2021
Q2 | $428K | Sell |
|
|||||
|
2021
Q1 | $424K | Sell |
|
|||||
|
2020
Q4 | $906K | Sell |
|
|||||
|
2020
Q3 | $1.05M | Sell |
|
|||||
|
2020
Q2 | $20.1M | Buy |
|
|||||
|
2020
Q1 | $18.6M | Buy |
|
|||||
|
2019
Q4 | $14.5M | Buy |
|
|||||
|
2019
Q3 | $13.3M | Buy |
|
|||||
|
2019
Q2 | $989K | Buy |
|
|||||
|
2019
Q1 | $401K | Buy |
|
|||||
|
2018
Q4 | $305K | Sell |
|
|||||
|
2018
Q3 | $987K | Buy |
|
|||||
|
2018
Q2 | $963K | Buy |
|
|||||
|
2018
Q1 | $481K | Sell |
|
|||||
|
2017
Q4 | $537K | Sell |
|
|||||
|
2017
Q3 | $850K | Sell |
|
|||||
|
2017
Q2 | $1.59M | Sell |
|
|||||
|
2017
Q1 | $2.48M | Sell |
|
|||||
|
2016
Q4 | $2.85M | Buy |
|
|||||
|
2016
Q3 | $2.45M | Sell |
|
|||||
|
2016
Q2 | $1.63M | Sell |
|
|||||
|
2016
Q1 | $2.57M | Buy |
|
|||||
|
2015
Q4 | $505K | Buy |
|
|||||
|
2015
Q3 | $259K | Sell |
|
|||||
|
2015
Q2 | $908K | Sell |
|
|||||
|
2015
Q1 | $602K | Buy |
|